Related Experiment Video
Updated: Sep 13, 2025

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
Published on: October 24, 2018
Urolithin A Abolishes High Anxiety and Rescues the Associated Mitochondria-Related Transcriptomic Signatures and
David Mallet1, Doğukan Hazar Ülgen1, Jocelyn Grosse1
1Laboratory of Behavioral Genetics, Brain Mind Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; Synapsy Center for Neuroscience and Mental Health Research, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Background:
Chronic anxiety is common, disabling, and often refractory to current therapies. Mounting evidence implicates mitochondrial abnormalities in anxiety-related phenotypes. Urolithin A (UA), a gut microbiota-derived metabolite known to enhance mitochondrial health, has shown neuroprotective effects. However, its potential to alleviate anxiety remains unexplored.
Methods:
UA was administered chronically to two validated rodent models of high anxiety: 1) outbred animals displaying natural variation in trait anxiety and 2) rats selectively bred for high stress reactivity; low-anxiety animals served as controls. Anxiety-like behaviors were assessed across multiple tasks. Molecular profiling of nucleus accumbens (NAc) medium spiny neurons (MSNs) was performed using single-nucleus RNA sequencing, with MitoPathway analysis to evaluate mitochondria-related transcriptomic signatures. Electrophysiological, immunohistochemical, and morphological approaches were used to assess synaptic and structural correlates.
Results:
UA produced a robust anxiolytic effect in both high-anxiety models in both sexes without altering behavior in low-anxiety animals. High-anxiety MSNs displayed coupled dysregulation of mitochondrial and synaptic gene pathways that UA normalized to low-anxiety levels across MSN subtypes. These changes were accompanied by structural and functional rescue of MSN dendritic architecture, spine density, and excitatory synaptic transmission. Notably, UA also restored expression of Mfn2, a mitochondrial protein causally involved in the regulation of anxiety-related behavior and circuit dysfunction in the NAc, further supporting a mechanistic link between mitochondrial remodeling and UA's anxiolytic efficacy.
Conclusions:
These findings position UA as a mechanistically supported intervention in preclinical models of heightened anxiety and provide systems-level insights into how mitochondrial pathways interface with synaptic function and circuit regulation in anxiety states.
Related Concept Videos
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

